EP 0604529 A1 19940706 - PYRIDINE COMPOUNDS FOR TREATING LEUKOTRIENE-RELATED DISEASES.
Title (en)
PYRIDINE COMPOUNDS FOR TREATING LEUKOTRIENE-RELATED DISEASES.
Title (de)
Pyridinverbindungen für die Behandlung von Leukotrien-verwandten Krankheiten.
Title (fr)
COMPOSES DE PYRIDINE UTILISES DANS LE TRAITEMENT DES MALADIES APPARENTEES AUX LEUCOTRIENES.
Publication
Application
Priority
- US 9207466 W 19920901
- US 76271091 A 19910919
- US 79093191 A 19911112
- US 80959391 A 19911218
- US 93286992 A 19920820
- CN 93103596 A 19930319
Abstract (en)
[origin: WO9306085A1] This invention relates to compounds of formula (I) which are useful as leukotriene antagonists.
Abstract (fr)
L'invention se rapporte aux composés de la formule (I) utilisés comme antagonistes des leucotriènes.
IPC 1-7
IPC 8 full level
A61K 31/44 (2006.01); A61K 31/4418 (2006.01); A61P 17/00 (2006.01); A61P 37/08 (2006.01); A61P 43/00 (2006.01); C07D 213/24 (2006.01); C07D 213/28 (2006.01); C07D 213/30 (2006.01); C07D 213/54 (2006.01); C07D 213/65 (2006.01); C07D 401/12 (2006.01)
CPC (source: EP)
A61P 17/00 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C07D 213/65 (2013.01); C07D 401/12 (2013.01)
Citation (search report)
See references of WO 9306085A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE
DOCDB simple family (publication)
WO 9306085 A1 19930401; AP 333 A 19940425; AP 9200428 A0 19921031; AU 2573592 A 19930427; CA 2119467 A1 19930401; CN 1092409 A 19940921; EP 0604529 A1 19940706; IL 103205 A0 19930221; JP H06510786 A 19941201; MA 22649 A1 19930401; MX 9205358 A 19930701; NZ 244371 A 19951127; PT 100881 A 19931029
DOCDB simple family (application)
US 9207466 W 19920901; AP 9200428 A 19920917; AU 2573592 A 19920901; CA 2119467 A 19920901; CN 93103596 A 19930319; EP 92920043 A 19920901; IL 10320592 A 19920917; JP 50606992 A 19920901; MA 22940 A 19920908; MX 9205358 A 19920921; NZ 24437192 A 19920917; PT 10088192 A 19920918